Bio Pharma Dive
JUNE 5, 2025
A deal worth up to $712 million with the China-based biotech gives Cullinan T cell engagers aimed at BCMA and CD19, two targets of interest in inflammatory conditions.
Pharmaceutical Technology
JUNE 5, 2025
Regeneron and Sanofis blockbuster Dupixent has transformed the atopic dermatitis market, with future disruptors in the pipeline.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JUNE 5, 2025
Skip to main content CONTINUE TO SITE ➞ Dont miss tomorrows biopharma industry news Let BioPharma Dives free newsletter keep you informed, straight from your inbox. Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy.
Scienmag
JUNE 5, 2025
Recent landmark findings from the NRG-NSABP B-51/RTOG 1304 clinical trial have delivered a paradigm-shifting insight into the management of breast cancer patients whose axillary lymph nodes convert from positive to negative status following neoadjuvant chemotherapy. The study’s latest data, published in the prestigious New England Journal of Medicine, challenges the long-held view that regional nodal irradiation (RNI) universally reduces invasive breast cancer recurrence and suggests a more nuan
Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group
Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable! Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. We'll explore innovative strategies to bring traditionally dry topics to life, making them resonate with learners and drive tangible change.
JAMA Internal Medicine
JUNE 5, 2025
This randomized clinical trial compares the effectiveness of mailed self-collection kits, with and without patient navigation, to telephone reminders to increase cervical cancer screening in a safety-net health system.
Scienmag
JUNE 5, 2025
In a groundbreaking cohort study published in JAMA Oncology , researchers have unveiled critical insights into the complex interplay between lifestyle factors and the risk of subsequent neoplasms among childhood cancer survivors. This comprehensive investigation sheds new light on how obesity and physical activity differentially influence the emergence of multiple new tumor types in this vulnerable population, emphasizing the urgent need for tailored lifestyle interventions aimed at mitigating l
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
JUNE 5, 2025
A groundbreaking study emerging from the research laboratories of Mass General Brigham has revealed compelling connections between brain health and systemic diseases that extend far beyond neurological disorders. The recent findings, published in the journal Family Practice , demonstrate that individuals with higher scores on the McCance Brain Care Score (BCS) display not only a reduced risk of brain-related conditions such as stroke, dementia, and depression but also a markedly lower likelihood
PharmTech
JUNE 5, 2025
News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer
STAT News
JUNE 5, 2025
In the late 2010s, scientists at the Danish drugmaker Novo Nordisk developed a new weekly obesity treatment that targeted three hormones at once. In mice studies , the drug, which activated receptors of the GLP-1, GIP, and glucagon hormones, caused notable weight loss. But Novo shelved the therapy. The company was concerned about potential side effects of targeting glucagon, like increasing blood sugar and heart rate.
Scienmag
JUNE 5, 2025
Dr. Warren Johnson, a distinguished figure in global health and professor emeritus of medicine at Weill Cornell Medicine, has been honored with the prestigious Joan and Sanford I. Weill Exemplary Achievement Award. This accolade, endowed with a $50,000 cash prize, acknowledges his extraordinary contributions to global health through decades of dedicated research, mentorship, and program development.
Advertisement
Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness
The Pharma Data
JUNE 5, 2025
A Life-Course Approach to Immunization: Prioritizing Vaccination at Every Age to Unlock the Full Potential of Lifelong Health In a striking demographic milestone, the global population is undergoing a historic transformation: for the first time ever, the number of adults over the age of 65 now exceeds that of children under the age of five. By 2030, nearly one billion people will fall into the 65-and-older age group, marking a seismic shift in age distribution across the world.
FDA Law
JUNE 5, 2025
By Jennifer D. Newberger — We have written many posts ( here , here , here , and more) about the impact of the reductions in force (RIFs) on various activities across FDA. One area where the RIFs are beginning to have an impact is with respect to Small Business Determination (SBD) requests submitted to CDRH. The Office of Management, which was eliminated in the April 1 RIF, was responsible for processing these requests, and generally did so within 60 days of receipt.
STAT News
JUNE 5, 2025
Global health threats don’t respect borders — they require strong collaborations and trust across partners. Yet a new policy from the National Institutes of Health blindsided U.S. researchers and could immediately upend the international research collaborations critical for understanding and responding to global health threats.
BioTech 365
JUNE 5, 2025
RAD 2025: Long-Term Data on Nemluvio® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to Two Years RAD 2025: Long-Term Data on Nemluvio® (nemolizumab) Demonstrate its … Continue reading →
Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk
In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?
pharmaphorum
JUNE 5, 2025
Brain-computer interface firm Neuralink has completed a $650m financing that it says will help to "bring our technology to more people"
Pharma Times
JUNE 5, 2025
Therapy indicated for children aged 3 to 14 at treatment initiation
Pharmaceutical Technology
JUNE 5, 2025
Vividion Therapeutics has secured worldwide rights for developing and commercialising VVD-214, the Werner helicase (WRN) covalent inhibitor.
Pharma Times
JUNE 5, 2025
New funding supports development of diagnostic platform
Advertisement
Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.
pharmaphorum
JUNE 5, 2025
Novo Nordisk's long-acting injectable Sogroya has been backed for NHS use in young people with growth hormone deficiency
Pharmaceutical Commerce
JUNE 5, 2025
In the first part of her Pharma Commerce video interview, Maggie McCullough, PolicyMaps CEO, explains how geospatial mapping can help identify and address emerging pharmacy deserts across the United States.
BioTech 365
JUNE 5, 2025
Tracer Biotechnologies Announces Strategic Partnership with QIAGEN to Advance Blood-Based MRD Testing for Solid Tumors Tracer Biotechnologies Announces Strategic Partnership with QIAGEN to Advance Blood-Based MRD Testing for Solid Tumors NEW YORK–(BUSINESS WIRE)–Tracer Biotechnologies, a leader in blood-based molecular diagnostics … Continue reading →
World of DTC Marketing
JUNE 5, 2025
We are drowning in misinformation. Scroll through social media, search for symptoms on Google, or wander through YouTube videos about “natural cures,” and you’ll see just how far the web has strayed from reality. The once-promised dream of democratized health information has turned into a dangerous free-for-all where unqualified influencers shout louder than doctors, conspiracy theorists rack up millions of views, and desperate people are left to figure out what’s true—on their own.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
BioTech 365
JUNE 5, 2025
Oncolytic Virus Immunotherapy Strategic Research Business Report 2025-2030: Surge in Clinical Trials Combining Oncolytic Viruses With Checkpoint Inhibitors Expands Therapeutic Horizons – ResearchAndMarkets.
Scienmag
JUNE 5, 2025
In an era where financial vulnerability is increasingly becoming a global concern, groundbreaking research has illuminated the intricate psychological, social, and health-related factors that predicate individuals’ risk of falling prey to financial exploitation. The study, led by Yang, Hackett, and Katta and published in Communications Psychology in early 2025, offers a comprehensive exploration of the multifaceted nature of financial victimization, moving beyond simplistic explanations to revea
BioTech 365
JUNE 5, 2025
MeMed BV Surpasses 100,000 Patient Tests, Underscoring Adoption of Rapid Host-Response Diagnostics MeMed BV Surpasses 100,000 Patient Tests, Underscoring Adoption of Rapid Host-Response Diagnostics — Milestone Achieved Through Growing Clinical Evidence Demonstrating Real-World Impact on Infection Management — — MeMed … Continue reading →
Rethinking Clinical Trials
JUNE 5, 2025
The Health Care Systems Research Network (HCSRN) will hold its 2026 Annual Conference from April 21 to 23, 2025, in Dallas, Texas. HCSRN is a 20-member research network focused on supporting research institutes aligned with healthcare delivery systems. HCSRNs mission is to improve individual and population health through research that connects the resources and capabilities of learning healthcare systems.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioTech 365
JUNE 5, 2025
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ® Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ® IXCHIQ® was … Continue reading →
STAT News
JUNE 5, 2025
On this week’s episode of “The Readout LOUD”: The Food and Drug Administration’s AI adventure, a deep look inside Novo Nordisk’s obesity stumble, and finally, another big M&A deal in biotech. The FDA has rolled out an internal AI tool called Elsa that, unlike its namesake Disney character, can’t seem to let go of mistakes.
BioTech 365
JUNE 5, 2025
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ® Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ® IXCHIQ® was … Continue reading →
STAT News
JUNE 5, 2025
Vijay Yadav warned people not to start downing taurine — an amino acid abundant in plants, animals and some energy drinks — just because his mice and monkey study suggested it might be an elixir for long life. But that doesn’t mean they listened. “The other day, I was talking to I think the scientific director of one of the largest pharma in the U.S., he was taking 14 grams of taurine per day,” said Yadav, or roughly 14 Red Bulls’ worth.
Expert insights. Personalized for you.
233 
Let's personalize your content